Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials
Venerdì 25 novembre 2022
circa 1 minuti di lettura
Journal and Affiliations:
European Heart Journal Cadiovascular Pharmacotherapy, 25 novembre 2022
Marco Valgimigli, Cardiocentro e Università della Svizzera italiana, Lugano
Tags:
aspirin
atrial fibrillation
dual antiplatelet therapy
monotherapy
oral anticoagulant therapy
P2Y12 inhibitor
percutaneous coronary intervention
Authors:
Marco Valgimigli